You can manage bookmarks using lists, please log in to your user account for this.
Media type:
E-Article
Title:
Futurescapes: expectations in Europe for relative effectiveness evidence for drugs in 2020
Contributor:
Towse, Adrian;
Garau, Martina;
Mohr, Penny;
Messner, Donna A
Published:
Becaris Publishing Limited, 2015
Published in:
Journal of Comparative Effectiveness Research, 4 (2015) 4, Seite 401-418
Language:
English
DOI:
10.2217/cer.15.7
ISSN:
2042-6305;
2042-6313
Origination:
Footnote:
Description:
Aim: Explore key factors influencing future expectations for the production of evidence of relative effectiveness (RE) for drugs in Europe in 2020; construct three plausible future scenarios for RE evidence generation. Materials & methods: Semi-structured key informant interviews and three rounds of modified Delphi to gather expert perspectives and develop future scenarios. Results & conclusion: Most influential factors were degree of regulator use of postmarketing authorization (postlaunch) efficacy studies and adaptive licensing; degree of pan-European health technology assessment body coordination in reviewing prelaunch evidence and demanding postlaunch studies; the nature of regulator – health technology assessment body interaction. The most likely scenario entailed some change with postlaunch regulatory studies driving the likely nature of RE evidence generated.